Clinical Trial Detail

NCT ID NCT01537744
Title A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

Azacitidine + Romidepsin

Age Groups: senior adult

No variant requirements are available.